Product Portfolio

Product Portfolio

Meda’s product portfolio is well diversified and spans several therapeutic and ¬product areas. Rx drugs account for around 60% of net sales, while non-prescription drugs – consisting of Cx and OTC products – account for around 40%.

Meda's products fall within several therapy areas but the main focus is Respiratory, Dermatology, and Pain and Inflammation.

For additional information about Meda's products and their availability see each country's local website.

Selected therapy areas and product areas

Our products

Meda has a well-diversified product portfolio, a global presence, and is represented within all areas of pharmaceuticals: Specialty Products, Cx, and OTC